Hologic Gross Margin 2012-2025 | HOLX
Current and historical gross margin for Hologic (HOLX) over the last 10 years. The current gross profit margin for Hologic as of December 31, 2025 is %.
| Hologic Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-12-31 | $4.13B | $2.12B | 51.44% |
| 2025-09-30 | $4.10B | $2.12B | 51.65% |
| 2025-06-30 | $4.04B | $2.09B | 51.82% |
| 2025-03-31 | $4.03B | $2.08B | 51.56% |
| 2024-12-31 | $4.04B | $2.24B | 55.48% |
| 2024-09-30 | $4.03B | $2.23B | 55.29% |
| 2024-06-30 | $3.99B | $2.17B | 54.43% |
| 2024-03-31 | $3.96B | $1.98B | 49.95% |
| 2023-12-31 | $3.97B | $2.02B | 50.94% |
| 2023-09-30 | $4.03B | $2.07B | 51.41% |
| 2023-06-30 | $4.04B | $2.09B | 51.68% |
| 2023-03-31 | $4.06B | $2.27B | 55.93% |
| 2022-12-31 | $4.47B | $2.63B | 58.89% |
| 2022-09-30 | $4.86B | $3.00B | 61.65% |
| 2022-06-30 | $5.23B | $3.31B | 63.34% |
| 2022-03-31 | $5.39B | $3.46B | 64.22% |
| 2021-12-31 | $5.49B | $3.60B | 65.56% |
| 2021-09-30 | $5.63B | $3.80B | 67.39% |
| 2021-06-30 | $5.66B | $3.90B | 68.87% |
| 2021-03-31 | $5.32B | $3.66B | 68.90% |
| 2020-12-31 | $4.54B | $2.97B | 65.56% |
| 2020-09-30 | $3.78B | $2.23B | 58.99% |
| 2020-06-30 | $3.30B | $1.55B | 46.91% |
| 2020-03-31 | $3.33B | $1.53B | 45.86% |
| 2019-12-31 | $3.39B | $1.17B | 34.57% |
| 2019-09-30 | $3.37B | $1.17B | 34.78% |
| 2019-06-30 | $3.31B | $1.34B | 40.49% |
| 2019-03-31 | $3.29B | $1.33B | 40.57% |
| 2018-12-31 | $3.26B | $1.71B | 52.38% |
| 2018-09-30 | $3.22B | $1.70B | 52.75% |
| 2018-06-30 | $3.21B | $1.69B | 52.82% |
| 2018-03-31 | $3.19B | $1.67B | 52.30% |
| 2017-12-31 | $3.12B | $1.64B | 52.71% |
| 2017-09-30 | $3.06B | $1.62B | 53.04% |
| 2017-06-30 | $2.98B | $1.61B | 53.99% |
| 2017-03-31 | $2.89B | $1.59B | 55.06% |
| 2016-12-31 | $2.87B | $1.59B | 55.35% |
| 2016-09-30 | $2.83B | $1.56B | 55.19% |
| 2016-06-30 | $2.81B | $1.54B | 54.70% |
| 2016-03-31 | $2.79B | $1.52B | 54.65% |
| 2015-12-31 | $2.75B | $1.47B | 53.60% |
| 2015-09-30 | $2.71B | $1.43B | 52.96% |
| 2015-06-30 | $2.66B | $1.40B | 52.52% |
| 2015-03-31 | $2.60B | $1.33B | 51.21% |
| 2014-12-31 | $2.57B | $1.28B | 49.73% |
| 2014-09-30 | $2.53B | $1.25B | 49.21% |
| 2014-06-30 | $2.49B | $1.19B | 47.81% |
| 2014-03-31 | $2.49B | $1.19B | 47.83% |
| 2013-12-31 | $2.47B | $1.19B | 47.94% |
| 2013-09-30 | $2.49B | $1.16B | 46.63% |
| 2013-06-30 | $2.46B | $1.15B | 46.58% |
| 2013-03-31 | $2.30B | $1.08B | 46.92% |
| 2012-12-31 | $2.16B | $1.03B | 47.55% |
| 2012-09-30 | $2.00B | $0.99B | 49.65% |
| 2012-06-30 | $1.88B | $0.96B | 51.20% |
| 2012-03-31 | $1.86B | $0.95B | 51.18% |
| 2011-12-31 | $1.83B | $0.95B | 51.80% |
| 2011-09-30 | $1.79B | $0.92B | 51.62% |
| 2011-06-30 | $1.75B | $0.78B | 44.43% |
| 2011-03-31 | $1.72B | $0.75B | 43.75% |
| 2010-12-31 | $1.70B | $0.75B | 43.88% |
| 2010-09-30 | $1.68B | $0.74B | 43.90% |
| 2010-06-30 | $1.65B | $0.85B | 51.21% |
| 2010-03-31 | $1.64B | $0.85B | 51.83% |
| 2009-12-31 | $1.62B | $0.84B | 52.10% |
| 2009-09-30 | $1.64B | $0.86B | 52.41% |
| 2009-06-30 | $1.68B | $0.89B | 53.13% |
| 2009-03-31 | $1.70B | $0.93B | 54.32% |
| 2008-12-31 | $1.73B | $0.96B | 55.14% |
| 2008-09-30 | $1.67B | $0.89B | 53.35% |
| 2008-06-30 | $1.43B | $0.75B | 52.37% |
| 2008-03-31 | $1.20B | $0.60B | 49.79% |
| 2007-12-31 | $0.95B | $0.44B | 46.46% |
| 2007-09-30 | $0.74B | $0.35B | 46.82% |
| 2007-06-30 | $0.69B | $0.31B | 45.36% |
| 2007-03-31 | $0.62B | $0.27B | 44.17% |
| 2006-12-31 | $0.54B | $0.23B | 42.94% |
| 2006-09-30 | $0.46B | $0.19B | 41.68% |
| 2006-06-30 | $0.39B | $0.16B | 41.09% |
| 2006-03-31 | $0.34B | $0.14B | 40.76% |
| 2005-12-31 | $0.31B | $0.12B | 40.13% |
| 2005-09-30 | $0.29B | $0.11B | 39.02% |
| 2005-06-30 | $0.27B | $0.10B | 37.73% |
| 2005-03-31 | $0.26B | $0.10B | 36.82% |
| 2004-12-31 | $0.25B | $0.09B | 36.33% |
| 2004-09-30 | $0.23B | $0.08B | 36.68% |
| 2004-06-30 | $0.22B | $0.08B | 37.33% |
| 2004-03-31 | $0.21B | $0.08B | 36.67% |
| 2003-12-31 | $0.20B | $0.07B | 36.27% |
| 2003-09-30 | $0.20B | $0.07B | 35.96% |
| 2003-06-30 | $0.20B | $0.07B | 36.18% |
| 2003-03-31 | $0.20B | $0.07B | 36.92% |
| 2002-12-31 | $0.19B | $0.07B | 37.70% |
| 2002-09-30 | $0.19B | $0.07B | 37.89% |
| 2002-06-30 | $0.19B | $0.07B | 35.98% |
| 2002-03-31 | $0.19B | $0.07B | 37.10% |
| 2001-12-31 | $0.18B | $0.07B | 35.33% |
| 2001-09-30 | $0.18B | $0.06B | 33.15% |
| 2001-06-30 | $0.16B | $0.05B | 31.06% |
| 2001-03-31 | $0.14B | $0.04B | 28.26% |
| 2000-12-31 | $0.12B | $0.04B | 29.91% |
| 2000-09-30 | $0.09B | $0.03B | 32.26% |
| 2000-06-30 | $0.09B | $0.03B | 37.21% |
| 2000-03-31 | $0.08B | $0.03B | 38.10% |
| 1999-12-31 | $0.08B | $0.03B | 37.50% |
| 1999-09-30 | $0.08B | $0.03B | 40.48% |
| 1999-06-30 | $0.09B | $0.04B | 44.94% |
| 1999-03-31 | $0.10B | $0.05B | 49.51% |
| 1998-12-31 | $0.11B | $0.06B | 51.75% |
| 1998-09-30 | $0.12B | $0.06B | 52.17% |
| 1998-06-30 | $0.12B | $0.06B | 53.04% |
| 1998-03-31 | $0.11B | $0.06B | 52.78% |
| 1997-12-31 | $0.11B | $0.06B | 53.77% |
| 1997-09-30 | $0.11B | $0.06B | 55.14% |
| 1997-06-30 | $0.11B | $0.03B | 27.36% |
| 1997-03-31 | $0.11B | $0.03B | 28.57% |
| 1996-12-31 | $0.10B | $0.02B | 25.00% |
| 1996-09-30 | $0.08B | $0.02B | 20.24% |
| 1996-06-30 | $0.07B | $0.04B | 56.16% |
| 1996-03-31 | $0.06B | $0.03B | 53.45% |
| 1995-12-31 | $0.05B | $0.03B | 52.08% |
| 1995-09-30 | $0.04B | $0.02B | 51.16% |
| 1995-06-30 | $0.04B | $0.02B | 47.50% |
| 1995-03-31 | $0.04B | $0.02B | 45.00% |
| 1994-12-31 | $0.04B | $0.02B | 46.34% |
| 1994-09-30 | $0.04B | $0.02B | 46.15% |
| 1994-06-30 | $0.04B | $0.02B | 48.57% |
| 1994-03-31 | $0.03B | $0.02B | 48.39% |
| 1993-12-31 | $0.03B | $0.01B | 48.15% |
| 1993-09-30 | $0.02B | $0.01B | 50.00% |
| 1993-06-30 | $0.03B | $0.01B | 48.00% |
| 1993-03-31 | $0.03B | $0.01B | 50.00% |
| 1992-12-31 | $0.03B | $0.01B | 50.00% |
| 1992-09-30 | $0.03B | $0.01B | 50.00% |
| 1992-06-30 | $0.02B | $0.01B | 54.17% |
| 1992-03-31 | $0.02B | $0.01B | 50.00% |
| 1991-12-31 | $0.02B | $0.01B | 50.00% |
| 1991-09-30 | $0.02B | $0.01B | 47.06% |
| 1991-03-31 | $0.01B | $0.01B | 42.86% |
| 1990-12-31 | $0.02B | $0.01B | 40.00% |
| 1990-06-30 | $0.02B | $0.01B | 37.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $16.752B | $4.101B |
| Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |